TB-500, derived from thymosin beta-4, contributes a complementary mechanism centered on actin cytoskeleton regulation and cellular migration
Duodenocutaneous fistula in rats as a model for wound healing-therapy in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine
Confirm your vial size
Many other factors could explain the results
Frequently Asked Questions About US Peptide Companies Who are the best peptide companies in the USA for 2026
TB-500, also written TB500, is the research-market designation for synthetic thymosin beta 4 (T4), a 43-residue N-terminally acetylated polypeptide, sequence Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES, molecular formula CHNOS, molecular weight 4963.4 g/mol, CAS 77591-33-4